Skip to main content

and
  1. No Access

    Article

    Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough

    Refractory chronic cough is a disabling disease with very limited therapeutic options. A better understanding of cough pathophysiology has led to the development of emerging drugs targeting cough receptors. Re...

    Laurent Guilleminault, Stanislas Grassin-Delyle, Stuart B. Mazzone in Drugs (2024)

  2. No Access

    Article

    Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys

    The objective of this study was to compare two different nebulizers: Eflow rapid® and Pari LC star® by scintigraphy and PK modeling to simulate epithelial lining fluid concentrations from measured plasma conce...

    Sandrine Marchand, Salim Bouchene, Michèle de Monte in Pharmaceutical Research (2015)

  3. No Access

    Article

    The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors

    Lung cancer is the leading cause of cancer-related death worldwide. The efficacy of current systemic treatments is limited, with major side effects and only modest survival improvements. Aerosols routinely use...

    Agnès Maillet, Laurent Guilleminault, Etienne Lemarié in Pharmaceutical Research (2011)